We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Indian Generics Maker Settles with Plaintiffs in U.S. Price-Fixing Case
Indian Generics Maker Settles with Plaintiffs in U.S. Price-Fixing Case
Two U.S. subsidiaries of Indian generics company Sun Pharmaceutical Industries have reached settlements totaling $85 million with plaintiffs in the companies’ drug-pricing antitrust litigation, said Sun in a statement.